| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| hpp-607 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hereditary pyropoikilocytosis[MeSHID:C563004] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| hpp-607 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hereditary pyropoikilocytosis[MeSHID:C563004] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| hpp-607 | aurora kinase c | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hereditary pyropoikilocytosis[MeSHID:C563004] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||